p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma

Journal of Pathology

Volumn 178, Issue 4, 1996, Pages 415-421

  Kusama, Kaoru ^a   Okutsu, Seijiro ^a   Takeda, Akio ^a   Himiya, Takao ^a   Kojima, Akira ^a   Kidokoro, Yoshihiro ^a   Chu, Ling ^a   Iwanari, Shinkichi ^a   Kudo, Itsuro ^a   Moro, Itaru ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Mouth; p53 gene; p53 protein; Squamous cell carcinoma

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EPITHELIUM DYSPLASIA; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 15844389852     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199604)178:4<415::AID-PATH548>3.0.CO;2-1     Document Type: Article

References (35)

1. . Fearon ER, Vogelstein B A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767
2. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991, 253: 49-52.
3. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351: 453-456.
4. Lane DP. p53, guardian of the genome. Nature 1992; 358: 15-16.
5. Farmer G, Bargonetti J, Zhu H, Feiedman P, Prywes R, Prives C. Wild-type p53 activates transcription in vitro. Nature 1992, 358: 83-86.
6. Ehyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M. Wild-type p53 inhibits oncogene-mediated focus formation. Proc Natl Acad Sci USA 1989; 86: 8763-8767.
7. Finlay CA, Hinds PW, Levine AJ The p53 protooncogene can act as a suppressor of transformation. Cell 1989; 57: 1083-1093.
8. Nigro JM, Baker SJ, Pretsinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 342: 705-708.
9. Deppert W, Busehhausen-Denker G, Patschinsky T, Stemmeyer K. Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. Oncogene 1990; 5: 1701-1706
10. Reich NC, Oren M, Levine AJ. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mot Cell Biol 1983, 3: 2143-2150
11. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 1988; 8: 531-539
12. Hsu CI, Metcaff AR, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-429.
13. Marks JR, Davidoff AM, Kerns BJ, et al. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 1991, 51: 2979-2984.
14. Miller CW, Aslo A, Tsay C, et al. Frequency and structure of p53 rearrangements in human osteosarcoma Cancer Res 1991, 50: 7950-7954
15. Bressak B, Kew M, Wands J, Osturk M. Selective G and T mutations of p53 gene in hepatocellular carcinoma from southern Africa Nature 1991, 350: 429-431.
16. Rodrigues NR, Rowan A, Smith MEF, et al. p53 mutations in colorectal cancer, Proc Natl Acad Sci USA 1990; 87: 7555-7559.
17. Catoretti G, Rilke F, Andreola S, D'Amato L, Delia D p53 expression in breast cancer. Int J Cancer 1988; 41: 178-183.
18. Van den Berg FM, Tigges AJ, Schipper MEI, Den Hartog-Jagar FCA, Kroes WGM, Walboomers JMM. Expression of the nuclear oneagene p53 in colon tumours. J Pathol 1989; 157: 193-199.
19. Bartek J, Iggo R, Gannon J, Lane DP. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990, 5: 893-899.
20. Iggo R, Gatter K, Bartek J, Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990, 335: 675-679.
21. Field JK, Spandidos DA, Malhri A, Gosney JR, Yiagnisis M. Stell PM Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991, 64: 573-577
22. Gusterson BA, Anbazhagen R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium Oncogene 1991; 6: 1785-1789
23. Ogden GM, Kiddie RA, Lunny DP, Lane AP. Assessment p53 protein expression in normal, benign, and malignant oral mucosa J Pathol 1992 166: 389-394.
24. Maestro R, Dolcetti R, Gasparotto D, et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx Oncogene 1992, 7: 1159-1166.
25. Burns JE, Baird MC, Clark LJ, et al. Gene mutation and increased levels of p53 protein in human squamous cell carcinomas and their cell lines Br J Cancer, 1993; 67: 1274-1284.
26. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes Oncogene 1992, 7: 927-933.
27. Warnakulasuriya KAAS, Johnson NW. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral ksions J Oral Pathol Med 1992; 21: 404-408.
28. Warnakulasunya KAAS, Johnson NW Association of overexpressioan of p53 oncoprotein with the state of cell proliferation in oral carcinoma J Oral Pathol Med 1994, 23: 246-250.
29. Hall PA, Lane DP, p53 in tumour pathology: can we trust immunohistochemistry? - revisitedt J Pathol 1994; 172: 1-4.
30. Watanabe H, Jass JR, Solin L. Histological Typing of Oesophageal and Gastric Tumours. 2nd edn Berlin: Springer-Verlag, 1990: 11-18
31. Beahrs OH, Henson DE, Hutter RVP, Myers MH. Manual for Staging of Cancer. 3rd edn. Philadelphia: J. B Lippincott 1988 31-32
32. Shi S-R, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741-748.
33. Henco K, Heibey M. Quantitative PCR. the determination of template copy numbers by temperature gradient gel electrophoresis (TGGE). Nucleic Acids Res 1990; 18: 6733-6734.
34. Mietz JA, Unger T, Huibregtse JM, Howley PM The transcriptional transactivation function of wild-type p53 is inhibited by SV 40 large T-antigen and by HPV-16 E6 protein. EMBO J 1992; 11: 5013-5020.
35. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992; 69: 1237-1245.